Latent Neural-ODE for Model-Informed Precision Dosing: Overcoming Structural Assumptions in Pharmacokinetics

2026-02-03

AI Summary

This study addresses the limitations of traditional population pharmacokinetic (PopPK) models, which rely on predefined structural assumptions and often fail to accurately capture individual tacrolimus pharmacokinetic dynamics, leading to model misspecification. To overcome this, the authors propose the first application of Latent Ordinary Differential Equations (Latent ODEs) in precision dosing, introducing a data-driven, individualized pharmacokinetic modeling framework. This approach enables end-to-end learning of individual drug dynamics from sparse clinical observations and achieves high-accuracy prediction of area under the concentration–time curve (AUC). In internal validation, the method attains a root mean squared percentage error (RMSPE) of 7.99%, significantly outperforming the it2B method (9.24%). External validation yields an RMSPE of 10.82%, comparable to standard approaches, demonstrating strong generalizability and robustness while transcending the structural constraints of conventional PopPK models.

Technology Category

• Machine Learning: Calibration & Uncertainty Quantification
• Search and Optimization: Mixed Discrete/Continuous Search
• Intelligent Robots: State Estimation

Application Category

• User Modeling, Personalization and Recommendation: On-Device user modeling, personalization, and recommendation
• Economics, Online Markets and Human Computation: Cost models of using LLMs in production systems
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking

Abstract

Accurate estimation of tacrolimus exposure, quantified by the area under the concentration-time curve (AUC), is essential for precision dosing after renal transplantation. Current practice relies on population pharmacokinetic (PopPK) models based on nonlinear mixed-effects (NLME) methods. However, these models depend on rigid, pre-specified assumptions and may struggle to capture complex, patient-specific dynamics, leading to model misspecification. In this study, we introduce a novel data-driven alternative based on Latent Ordinary Differential Equations (Latent ODEs) for tacrolimus AUC prediction. This deep learning approach learns individualized pharmacokinetic dynamics directly from sparse clinical data, enabling greater flexibility in modeling complex biological behavior. The model was evaluated through extensive simulations across multiple scenarios and benchmarked against two standard approaches: NLME-based estimation and the iterative two-stage Bayesian (it2B) method. We further performed a rigorous clinical validation using a development dataset (n = 178) and a completely independent external dataset (n = 75). In simulation, the Latent ODE model demonstrated superior robustness, maintaining high accuracy even when underlying biological mechanisms deviated from standard assumptions. Regarding experiments on clinical datasets, in internal validation, it achieved significantly higher precision with a mean RMSPE of 7.99% compared with 9.24% for it2B (p<0.001). On the external cohort, it achieved an RMSPE of 10.82%, comparable to the two standard estimators (11.48% and 11.54%). These results establish the Latent ODE as a powerful and reliable tool for AUC prediction. Its flexible architecture provides a promising foundation for next-generation, multi-modal models in personalized medicine.

Problem

• pharmacokinetics
• model misspecification
• precision dosing
• tacrolimus
• AUC prediction

Innovation

• Latent ODE
• precision dosing
• pharmacokinetics
• deep learning
• AUC prediction